Amazon Joins with Berkshire Hathaway, JPMorgan to Form Health-care Company

By Matt Day / The Seattle Times

The three U.S. corporate giants say their new venture will work to improve employee care and lower costs "free from profit-making incentives and constraints."

Amazon  — thought for years to be weighing an entry into health care — landed there with an unexpected splash Tuesday, revealing plans to form a joint venture with Warren Buffett’s Berkshire Hathaway and JPMorgan Chase that’s charged with lowering the cost of caring for employees.

How Fetal Infections Lead to Adult Heart Disease

By Leila Gray / UW Medicine

Recent studies indicate that infants born prematurely have a higher risk of developing heart disease later in life. Now, researchers at the University of Washington School of Medicine in Seattle have shown that, in preterm animal models, inflammation due to infection can disrupt the activity of genes crucial for normal heart development.

An STI That You Probably Don't Even Know about Is Becoming Common and Resistant to Medications

By Melissa Matthews / Newsweek

You’ve likely never heard of, or been tested for it, but a sexually transmitted infection that’s fairly common could now be resistant to antibiotic medications. Mycoplasma genitalium, or MG, is not a new bacteria and was first identified in the 1980s. According to the Centers for Disease Control and Prevention, it is more common than gonorrhea and chlamydia, though it's not as easily recognized as the other two.

STATEMENT: Standing with all our students, staff and faculty - A response to heated language about immigration

Dear students, faculty and staff:

At the University of Washington, we are honored to collaborate with students, faculty and staff from around the globe. The Department of Global Health, our School of Public Health, and our University would not be the world-class institutions they are without their contributions.

What Must Countries Prioritize to Deliver Universal Health Coverage?

By Disease Control Priorities (DCP3)

Disease Control Priorities (DCP3), a UW Department of Global Health program, provides up-to-date evidence on priorities that countries should consider in order to deliver universal health coverage. DCP3 launched their latest findings on December 6 at a standing-room only event in London co-hosted by The Lancet. The event began with keynote addresses from Richard Horton, editor-in-chief of The Lancet, and World Health Organization Director-General, Dr. Tedros Ghebreyesus. 

Pages